| CTRI Number |
CTRI/2025/06/088387 [Registered on: 06/06/2025] Trial Registered Prospectively |
| Last Modified On: |
27/05/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Dentistry |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
Combining Local Anaesthetics with steroid: Applications in Lower Third Molar Surgeries |
|
Scientific Title of Study
|
Combining Local Anaesthetics with Triamcinolone Acetonide: Applications in lower Third Molar Surgeries |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Avni Maheshwari |
| Designation |
PG student |
| Affiliation |
Jaipur Dental College |
| Address |
Department Of Oral And Maxillofacial Surgery
Jaipur RAJASTHAN 302028 India |
| Phone |
08764185165 |
| Fax |
|
| Email |
avnipartani@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Avni Maheshwari |
| Designation |
PG student |
| Affiliation |
Jaipur dental College |
| Address |
Department Of Oral And Maxillofacial Surgery
Jaipur RAJASTHAN 302028 India |
| Phone |
08764185165 |
| Fax |
|
| Email |
avnipartani@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Avni Maheshwari |
| Designation |
PG student |
| Affiliation |
Jaipur Dental College |
| Address |
Department Of Oral And Maxillofacial Surgery
Jaipur RAJASTHAN 302028 India |
| Phone |
08764185165 |
| Fax |
|
| Email |
avnipartani@gmail.com |
|
|
Source of Monetary or Material Support
|
| Department Of Oral And Maxillofacial Surgery, Jaipur dental College
Maharaj Vinayak Global University 302028- infrastructure, patient support |
|
|
Primary Sponsor
|
| Name |
Dr Avni Maheshwari |
| Address |
Jaipur Dental College
Maharaj Vinayak Global University 302028 |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Avni Maheshwari |
Gomtipur Referral Hospital |
Room No 3
Rupani Dental Care Ahmadabad GUJARAT |
8764185165
avnipartani@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Maharaj Vinayak Global University |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: K039||Disease of hard tissues of teeth,unspecified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Lignocaine 2% with 1:80,000 adrenaline |
this will be used as nerve block in one group as inferior alveolar nerve block |
| Intervention |
Triamcinolone Acetonide 40mg with Lignocaine 2% with 1:80,000 adrenaline |
this will be used as nerve block in one group as inferior alveolar nerve block |
|
|
Inclusion Criteria
|
| Age From |
19.00 Year(s) |
| Age To |
50.00 Year(s) |
| Gender |
Both |
| Details |
Both male and female patients
Age group of 18 to 50 years
Patients with impacted mandibular third molar
Patients with NO systemic illness
Patients not allergic to bupivacaine
Patients willing to give the consent
Patients willing to come for a follow-up
|
|
| ExclusionCriteria |
| Details |
Patients above the age of 50 years
Patients with erupted/non-impacted lower third molar
Patients with systemic illness/immunocompromised status
Patients not willing to give consent
Patients allergic to triamcinolone acetonide and bupivacaine
Noncompliance of patient in taking postoperative medication
Inability to appear for follow-up
Local pathology like cyst/tumor associated with third molar
|
|
|
Method of Generating Random Sequence
|
Other |
|
Method of Concealment
|
Alternation |
|
Blinding/Masking
|
Participant Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Pain Managment |
1 day, 3rd day, 7 day |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| postoperative discomfort analysis |
1 day, 3rd day, 7th day |
|
|
Target Sample Size
|
Total Sample Size="75" Sample Size from India="75"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2/ Phase 3 |
|
Date of First Enrollment (India)
|
30/06/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="1" Days="15" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
- This study will be
conducted in the out-patient clinic of Department of OMFS, Jaipur Dental
College, Jaipur, Rajasthan
- The study will be
a Clinical Trial, wherein 25+25+25 patients will be undertaken in each
group.
- Written consent
would be obtained from the patient after explaining the study and the
motive behind it
- 25 patients will receive
lignocaine 2% as local anesthetic solution.
- 25 patients will receive a
combination of triamcinolone acetonide 40mg with lignocaine 2% as local
anesthetic solution
- 25 patients will
receive a combination of triamcinolone acetonide 40mg with bupivacaine
0.5% as LA solution.
- The study would be
conducted in accordance with the Helsinki Declaration of 1975, revised in
2000
- Postoperative
instructions will be given to patients to bite on the cotton gauze firmly
for 10-20 minutes, to avoid spitting for 24 hours, to continue prescribed
medications regularly, to apply ice pack extra orally within 24 hours of
surgery, to carry out warm saline rinsing after 24 hours of surgery and to
refrain from smoking and vigorous oral rinsing.
- Patients to be
evaluated on the 2nd,3rd , 5th and 7th postoperative day
|